Trials / Terminated
TerminatedNCT00210002
Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced
Evaluation of Systematic Intravenous Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced.
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 55 (planned)
- Sponsor
- Institut Claudius Regaud · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the response rate obtained in an heterogeneous oncologic population treated by chemotherapy, and either by Darbepoetin alfa classic treatment or by association of Darbepoetin alfa -ferric saccharose systematic supplementation, administered concomitantly with chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Darbepoetin alfa (Aranesp®) | |
| DRUG | Ferric saccharose(Venofer®) |
Timeline
- Start date
- 2003-11-01
- Completion
- 2006-04-01
- First posted
- 2005-09-21
- Last updated
- 2006-11-14
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00210002. Inclusion in this directory is not an endorsement.